Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biodesix, Inc. - Common Stock (NQ:BDSX)

0.4481 -0.0019 (-0.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Biodesix to Participate in Two Upcoming Investor Conferences in September
From Biodesix, Inc.
Via Business Wire
Looking Into Biodesix's Return On Capital Employed
Benzinga Pro data, Biodesix (NASDAQ:BDSX) reported Q2 sales of $10.95 million. Earnings fell to a loss of $15.82 million, resulting in a 1.53% decrease from last quarter. 
Via Benzinga
Biodesix Named a Top 100 Healthcare Technology Company of 2022
From Biodesix, Inc.
Via Business Wire
Biodesix: Q2 Earnings Insights
  Biodesix (NASDAQ:BDSX) reported its Q2 earnings results on Thursday, August 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Biodesix Q1 Earnings
Biodesix (NASDAQ:BDSX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Biodesix Announces Second Quarter 2022 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million. 
Via Benzinga
Biodesix to Present Data at IASLC 2022 World Conference Demonstrating that the VeriStrat® Test is Predictive of Progression Free Survival and Overall Survival in Patients with Low or Negative PD-L1 Treated with Immune Checkpoint Inhibitors
From Biodesix, Inc.
Via Business Wire
Biodesix to Report Second Quarter 2022 Financial Results on August 4, 2022
From Biodesix, Inc.
Via Business Wire
Looking Into Biodesix's Return On Capital Employed
Benzinga Pro data, Biodesix (NASDAQ:BDSX) reported Q1 sales of $6.55 million. Earnings fell to a loss of $15.59 million, resulting in a 17.35% decrease from last quarter. 
Via Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase... 
Via Benzinga
Biodesix Obtains Medicare Coverage for the Nodify CDT® Lung Nodule Test
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Vaxxinity (NASDAQ:VAXX) stock moved upwards by 10.2% to $3.56 during Monday's after-market session. The company's market cap stands at $448.5 million. 
Via Benzinga
Biodesix Announces Research Agreement with Top US Cancer Center
From Biodesix, Inc.
Via Business Wire
Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference
From Biodesix, Inc.
Via Business Wire
Biodesix to Present at the H.C. Wainwright Global Investment Conference
From Biodesix, Inc.
Via Business Wire
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to be Presented at ATS 2022 International Conference
From Biodesix, Inc.
Via Business Wire
Biodesix Announces First Quarter 2022 Results and Highlights
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Biodesix to Report First Quarter 2022 Financial Results on May 11, 2022
From Biodesix, Inc.
Via Business Wire
66 Biggest Movers From Yesterday
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022
Upgrades 
Via Benzinga
68 Biggest Movers From Yesterday
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million. 
Via Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
A Peek Into The Markets: US Stock Futures Down Ahead Of March Inflation Report
Pre-open movers U.S. stock futures traded lower in early premarket trade after the Nasdaq Composite index closed at 13,411.96, a dip of almost 300 points. Investors are awaiting the annual inflation... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
Why This Nano-Cap Healthcare Stock Spiked Over 80% After-Hours Today
Shares of Biodesix, Inc. (NASDAQ: BDSX), a lung disease-focused diagnostics company, skyrocketed in after-hours trading on Monday. 
Via Benzinga
Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan
From Biodesix, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.